Mörike K - Search Results

1

Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial.

Mörike K, Kivistö KT, Schaeffeler E, Jägle C, Igel S, Drescher S, Fux R, Marx C, Hofmann U, Engel C, Wagner F, Delabar U, Meisner C, Bail D, Böhm JO, Gleiter CH, Ziemer G, Rein JG, Hellberg KD, Eichelbaum M, Schwab M. Mörike K, et al. Clin Pharmacol Ther. 2008 Jul;84(1):104-10. doi: 10.1038/sj.clpt.6100473. Epub 2008 Jan 2. Clin Pharmacol Ther. 2008. PMID: 18167502 Clinical Trial.

2

Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.

Fux R, Mörike K, Pröhmer AM, Delabar U, Schwab M, Schaeffeler E, Lorenz G, Gleiter CH, Eichelbaum M, Kivistö KT. Fux R, et al. Among authors: morike k. Clin Pharmacol Ther. 2005 Oct;78(4):378-87. doi: 10.1016/j.clpt.2005.07.004. Clin Pharmacol Ther. 2005. PMID: 16198657 Clinical Trial.

3

Effect of high-dose metronidazole on pharmacokinetics of oral budesonide and vice versa: a double drug interaction study.

Dilger K, Fux R, Röck D, Mörike K, Gleiter CH. Dilger K, et al. Among authors: morike k. J Clin Pharmacol. 2007 Dec;47(12):1532-9. doi: 10.1177/0091270007308617. J Clin Pharmacol. 2007. PMID: 18048573 Clinical Trial.

4

Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.

Busse D, Fromm MF, Mörike K, Drescher S, Kühlkamp V, Eichelbaum M. Busse D, et al. Among authors: morike k. Clin Pharmacol Ther. 2001 May;69(5):324-32. doi: 10.1067/mcp.2001.115125. Clin Pharmacol Ther. 2001. PMID: 11372000 Clinical Trial.

5

Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety.

Fux R, Greiner D, Geldmacher M, Mörike K, Gleiter CH. Fux R, et al. Among authors: morike k. Int J Clin Pharmacol Ther. 2006 Nov;44(11):539-47. doi: 10.5414/cpp44539. Int J Clin Pharmacol Ther. 2006. PMID: 17176620

6

Psoriasis aggravation and metoprolol treatment -- a prospective observational case study.

Fux R, Mörike K, Pröhmer AM, Delabar U, Schaeffeler E, Gleiter CH, Schwab M. Fux R, et al. Among authors: morike k. Int J Clin Pharmacol Ther. 2007 Dec;45(12):659-61. doi: 10.5414/cpp45659. Int J Clin Pharmacol Ther. 2007. PMID: 18184534 Clinical Trial. No abstract available.

7

Mechanisms and assessment of statin-related muscular adverse effects.

Moßhammer D, Schaeffeler E, Schwab M, Mörike K. Moßhammer D, et al. Among authors: morike k. Br J Clin Pharmacol. 2014 Sep;78(3):454-66. doi: 10.1111/bcp.12360. Br J Clin Pharmacol. 2014. PMID: 25069381 Free PMC article. Review.

8

Clinical pharmacokinetics of candesartan.

Gleiter CH, Mörike KE. Gleiter CH, et al. Clin Pharmacokinet. 2002;41(1):7-17. doi: 10.2165/00003088-200241010-00002. Clin Pharmacokinet. 2002. PMID: 11825094 Review.

9

Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.

Lutz M, Schwab M, Griese EU, Marx C, Müller-Oerlinghausen B, Schönhöfer PS, Meisner C, Gleiter CH, Eichelbaum M, Mörike K. Lutz M, et al. Among authors: morike k. Pharmacogenetics. 2002 Jan;12(1):73-5. doi: 10.1097/00008571-200201000-00010. Pharmacogenetics. 2002. PMID: 11773867

10

[Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy].

Fux R, Meisner C, Schwab M, Lorenz G, Mörike K, Gleiter CH. Fux R, et al. Among authors: morike k. Z Arztl Fortbild Qualitatssich. 2004 Nov;98(8):689-94. Z Arztl Fortbild Qualitatssich. 2004. PMID: 15646732 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters